Pfizer CEO Albert Bourla tests COVID positive
New York: Pfizer Inc Chief Executive Officer Albert Bourla has said that he had tested positive for COVID-19 and was experiencing very mild symptoms.Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.Read also: S Sridhar resigns as MD of PfizerPaxlovid is an antiviral medication that...
Login or Register to read the full article
New York: Pfizer Inc Chief Executive Officer Albert Bourla has said that he had tested positive for COVID-19 and was experiencing very mild symptoms.
Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.
Read also: S Sridhar resigns as MD of Pfizer
Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.
Bourla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech.
Read also: Pfizer to purchase Global Blood Therapeutics for USD 5.4 Billion
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd